Clinical Trial: Intravenous Tirofiban After Delayed Thrombolysis in Stroke

U.S., Aug. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07111806) titled 'Intravenous Tirofiban After Delayed Thrombolysis in Stroke' on Aug. 01.

Brief Summary: A multicenter, double-blind, double-dummy, randomized trial evaluating the efficacy and safety of intravenous tirofiban in acute ischemic stroke (AIS) patients without large/medium vessel occlusion, who presented 4.5-24 hours after onset and received intravenous thrombolysis (IVT).

Study Start Date: Dec. 01, 2025

Study Type: INTERVENTIONAL

Condition: Acute Ischemic Stroke

Intervention: DRUG: Tirofiban

Tirofiban is administered as a loading dose and continuous intravenous infusion as soon as possible after the randomization.

DRUG: Placebo

M...